Balance Sheet Soligenix, Inc.

Equities

SNGX

US8342236044

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 04:00:00 2024-09-10 pm EDT			5-day change	1st Jan Change
3.540 ^USD	-3.80%		-7.09%	-70.78%

Aug. 18	Transcript : Soligenix, Inc. - Special Call
Aug. 09	Soligenix, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	CI

5adacd6e5dacbecbf89d.06Sm9d82-v338AQWj1_iuLHqDjE6y3OOBVSnXHFAFzc.5f3Pj5xUjpKboGUl6yvT-cOPVmZNoQPMTC2TbhkRTmeq3JXN5nuZt7DBNA

Published financial data: SOLIGENIX, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Revenues	4.63M	2.36M	824K	949K	839K
Total Revenues	4.63M	2.36M	824K	949K	839K
Cost of Goods Sold, Total	3.57M	1.82M	729K	551K	742K
Gross Profit	1.06M	538K	95.63K	398K	97.31K
Selling General & Admin Expenses, Total	3.48M	3.98M	4.85M	6.69M	4.48M
R&D Expenses	8.12M	15.15M	8.39M	7.94M	3.31M
Other Operating Expenses, Total	11.6M	19.13M	13.24M	14.64M	7.8M
Operating Income	-10.54M	-18.59M	-13.14M	-14.24M	-7.7M
Interest Expense, Total	-	-10.88K	-863K	-823K	-49.13K
Interest And Investment Income	149K	-	-	-	-
Net Interest Expenses	149K	-10.88K	-863K	-823K	-49.13K
Currency Exchange Gains (Loss)	-7.81K	-23.38K	-39.36K	-30.55K	1.48K
Other Non Operating Income (Expenses)	434K	95.36K	206K	139K	231K
EBT, Excl. Unusual Items	-9.97M	-18.53M	-13.84M	-14.95M	-7.51M
In Process R&D Expenses	-	-	-	-	-
Other Unusual Items	-	-	422K	-	-394K
EBT, Incl. Unusual Items	-9.97M	-18.53M	-13.42M	-14.95M	-7.91M
Income Tax Expense	-611K	-837K	-865K	-1.15M	-1.77M
Earnings From Continuing Operations	-9.36M	-17.69M	-12.55M	-13.8M	-6.14M
Net Income to Company	-9.36M	-17.69M	-12.55M	-13.8M	-6.14M
Net Income - (IS)	-9.36M	-17.69M	-12.55M	-13.8M	-6.14M
Net Income to Common Incl Extra Items	-9.36M	-17.69M	-12.55M	-13.8M	-6.14M
Net Income to Common Excl. Extra Items	-9.36M	-17.69M	-12.55M	-13.8M	-6.14M
Per Share Items
Net EPS - Basic	-115.88	-154.45	-75.06	-76.89	-12.66
Basic EPS - Continuing Operations	-115.88	-154.45	-75.06	-76.89	-12.66
Basic Weighted Average Shares Outstanding	80.74K	115K	167K	179K	485K
Net EPS - Diluted	-115.88	-154.45	-75.06	-76.96	-12.66
Diluted EPS - Continuing Operations	-115.88	-154.45	-75.06	-76.96	-12.66
Diluted Weighted Average Shares Outstanding	80.74K	115K	167K	179K	485K
Normalized Basic EPS	-77.15	-101.1	-51.72	-52.08	-9.69
Normalized Diluted EPS	-77.15	-101.1	-51.72	-52.08	-9.69
Supplemental Items
EBITDA	-10.49M	-18.54M	-13.12M	-14.22M	-7.69M
EBITA	-10.51M	-18.57M	-13.14M	-14.24M	-7.7M
EBIT	-10.54M	-18.59M	-13.14M	-14.24M	-7.7M
EBITDAR	-10.35M	-18.4M	-12.99M	-14.09M	-7.56M
Total Revenues (As Reported)	4.63M	2.36M	824K	949K	839K
Effective Tax Rate - (Ratio)	6.13	4.52	6.45	7.72	22.35
Normalized Net Income	-6.23M	-11.58M	-8.65M	-9.35M	-4.7M
Interest on Long-Term Debt	1.74K	39.27K	711K	899K	565K
Supplemental Operating Expense Items
General and Administrative Expenses	3.48M	3.98M	4.85M	6.69M	4.48M
Research And Development Expense From Footnotes	11.69M	16.97M	9.12M	8.49M	4.05M
Net Rental Expense, Total	141K	140K	133K	135K	136K
Imputed Operating Lease Interest Expense	-	2.29K	89.88K	87.88K	7.78K
Imputed Operating Lease Depreciation	-	138K	43.42K	47.01K	128K
Stock-Based Comp., R&D Exp. (Total)	143K	196K	158K	143K	150K
Stock-Based Comp., G&A Exp. (Total)	233K	214K	203K	191K	270K
Stock-Based Comp., Other (Total)	159K	59K	27.5K	212K	73K
Total Stock-Based Compensation	536K	469K	389K	545K	493K

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	5.42M	18.68M	26.04M	13.36M	8.45M
Total Cash And Short Term Investments	5.42M	18.68M	26.04M	13.36M	8.45M
Accounts Receivable, Total	1.02M	204K	139K	115K	171K
Other Receivables	444K	361K	104K	104K	23.89K
Total Receivables	1.46M	565K	243K	219K	195K
Prepaid Expenses	610K	225K	283K	274K	866K
Total Current Assets	7.49M	19.47M	26.57M	13.85M	9.51M
Gross Property Plant And Equipment	-	410K	296K	474K	363K
Accumulated Depreciation	-	-159K	-168K	-115K	-121K
Net Property Plant And Equipment	162K	252K	128K	359K	242K
Other Intangibles, Total	58.45K	23.25K	7.75K	0	-
Deferred Charges Long-Term	39.32K	53.52K	20.27K	20.21K	-
Other Long-Term Assets, Total	22.76K	95.92K	144K	46.89K	48.24K
Total Assets	7.78M	19.89M	26.87M	14.28M	9.8M
Liabilities
Accounts Payable, Total	2.74M	2.13M	2.93M	3.87M	1.11M
Accrued Expenses, Total	3.46M	3.51M	3.26M	2.64M	2.67M
Short-term Borrowings	-	-	-	-	-
Current Portion of Long-Term Debt	-	325K	-	9.9M	2.25M
Current Portion of Leases	121K	112K	106K	109K	122K
Other Current Liabilities	-	-	-	-	-
Total Current Liabilities	6.31M	6.08M	6.29M	16.52M	6.15M
Long-Term Debt	-	9.95M	9.86M	-	1.01M
Long-Term Leases	6.15K	116K	-	234K	112K
Total Liabilities	6.32M	16.15M	16.15M	16.75M	7.27M
Preferred Stock Redeemable	-	-	-	43	-
Total Preferred Equity	-	-	-	43	-
Common Stock, Total	21.75K	30.64K	42.87K	2.91K	10.38K
Additional Paid In Capital	177M	197M	216M	217M	228M
Retained Earnings	-176M	-193M	-206M	-220M	-226M
Comprehensive Income and Other	-45.01K	-24.34K	41.94K	24.75K	22.24K
Total Common Equity	1.46M	3.74M	10.72M	-2.47M	2.52M
Total Equity	1.46M	3.74M	10.72M	-2.47M	2.52M
Total Liabilities And Equity	7.78M	19.89M	26.87M	14.28M	9.8M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	107K	167K	179K	183K	658K
ECS Total Common Shares Outstanding	90.64K	128K	179K	182K	649K
Book Value / Share	16.08	29.31	60.02	-13.59	3.89
Tangible Book Value	1.4M	3.72M	10.71M	-2.47M	2.52M
Tangible Book Value Per Share	15.43	29.12	59.98	-13.59	3.89
Total Debt	127K	10.51M	9.96M	10.24M	3.49M
Net Debt	-5.29M	-8.17M	-16.08M	-3.12M	-4.95M
Debt Equivalent Oper. Leases	1.13M	1.12M	1.07M	1.08M	1.09M
Account Code - Inventory Valuation	3	3	3	3	3
Machinery, Total	-	182K	190K	133K	133K
Full Time Employees	15	17	13	13	13
Part Time Employees	1	1	2	2	2

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	-9.36M	-17.69M	-12.55M	-13.8M	-6.14M
Depreciation & Amortization - CF	19.54K	158K	135K	130K	118K
Amortization of Goodwill and Intangible Assets - (CF)	27.16K	19.7K	-	-	-
Depreciation & Amortization, Total	46.7K	178K	135K	130K	118K
Amortization of Deferred Charges, Total - (CF)	7.75K	78.31K	57.43K	49.29K	12.52K
(Gain) Loss From Sale Of Asset	-3.84K	-	-	-	-
Asset Writedown & Restructuring Costs	-	5M	-	-	-
Stock-Based Compensation (CF)	536K	469K	389K	545K	493K
Other Operating Activities, Total	123K	-	-422K	-	351K
Change In Accounts Receivable	183K	815K	64.88K	23.76K	-56.12K
Change In Accounts Payable	1.97M	-1.16M	1.13M	397K	-2.69M
Change In Income Taxes	-	-	-	-	-
Change in Other Net Operating Assets	-1.01M	851K	-541K	4.7K	-696K
Cash from Operations	-7.51M	-11.45M	-11.74M	-12.65M	-8.6M
Capital Expenditure	-30.21K	-7.15K	-11.79K	-13.07K	-
Sale of Property, Plant, and Equipment	5.5K	-	-	-	-
Sale (Purchase) of Intangible assets	-	-	-	-	-
Cash from Investing	-24.71K	-7.15K	-11.79K	-13.07K	-
Long-Term Debt Issued, Total	-	10.42M	-	-	-
Total Debt Issued	-	10.42M	-	-	-
Short Term Debt Repaid, Total	-	-	-	-	-
Long-Term Debt Repaid, Total	-6.8K	-7.52K	-6.15K	-	-7M
Total Debt Repaid	-6.8K	-7.52K	-6.15K	-	-7M
Issuance of Common Stock	4.14M	15.06M	19.73M	79.35K	11.59M
Other Financing Activities, Total	-132K	-798K	-667K	-2.53K	-927K
Cash from Financing	4.01M	24.68M	19.06M	76.82K	3.66M
Foreign Exchange Rate Adjustments	-34.19K	40.88K	60.64K	-99.01K	27.15K
Net Change in Cash	-3.56M	13.26M	7.37M	-12.68M	-4.91M
Supplemental Items
Cash Interest Paid	-	34.41K	669K	857K	552K
Cash Income Tax Paid (Refund)	11.13K	4.02K	7.73K	16.04K	20.73K
Levered Free Cash Flow	-4.76M	-10.17M	-7.38M	-8.35M	-7.52M
Unlevered Free Cash Flow	-4.76M	-10.17M	-6.88M	-7.87M	-7.5M
Change In Net Working Capital	-1.27M	-735K	-806K	-357K	3.3M
Net Debt Issued / Repaid	-6.8K	10.41M	-6.15K	-	-7M

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	-72.13	-83.98	-35.13	-43.25	-39.97
Return on Total Capital	-167.54	-146.74	-47.02	-62.55	-69.8
Return On Equity %	-241.83	-680.46	-173.54	-334.43	-23.78K
Return on Common Equity	-241.83	-680.46	-173.54	-334.43	-23.8K
Margin Analysis
Gross Profit Margin %	22.95	22.82	11.6	41.95	11.59
SG&A Margin	75.18	168.65	588.05	705.32	534.04
EBITDA Margin %	-226.66	-785.76	-1.59K	-1.5K	-916.34
EBITA Margin %	-227.09	-786.91	-1.59K	-1.5K	-917.12
EBIT Margin %	-227.67	-787.75	-1.59K	-1.5K	-917.12
Income From Continuing Operations Margin %	-202.07	-749.69	-1.52K	-1.45K	-731.6
Net Income Margin %	-202.07	-749.69	-1.52K	-1.45K	-731.6
Net Avail. For Common Margin %	-202.07	-749.69	-1.52K	-1.45K	-731.6
Normalized Net Income Margin	-134.54	-490.72	-1.05K	-984.9	-559.56
Levered Free Cash Flow Margin	-102.86	-431.08	-894.86	-879.43	-895.45
Unlevered Free Cash Flow Margin	-102.86	-430.85	-834.54	-829.63	-893.28
Asset Turnover
Asset Turnover	0.51	0.17	0.04	0.05	0.07
Fixed Assets Turnover	51.12	11.42	4.34	3.89	2.79
Receivables Turnover (Average Receivables)	4.17	3.86	4.81	7.47	5.86
Short Term Liquidity
Current Ratio	1.19	3.2	4.22	0.84	1.55
Quick Ratio	1.09	3.16	4.18	0.82	1.4
Operating Cash Flow to Current Liabilities	-1.19	-1.88	-1.87	-0.77	-1.4
Days Sales Outstanding (Average Receivables)	87.53	94.83	75.87	48.85	62.27
Average Days Payable Outstanding	248.71	488.95	1.27K	2.25K	1.22K
Long Term Solvency
Total Debt/Equity	8.73	280.78	92.91	-414.45	138.54
Total Debt / Total Capital	8.03	73.74	48.16	131.8	58.08
LT Debt/Equity	0.42	269.09	91.92	-9.46	44.51
Long-Term Debt / Total Capital	0.39	70.67	47.65	3.01	18.66
Total Liabilities / Total Assets	81.26	81.19	60.09	117.3	74.25
EBIT / Interest Expense	-	-1.71K	-15.23	-17.31	-156.69
EBITDA / Interest Expense	-	-1.69K	-15.06	-17.12	-153.79
(EBITDA - Capex) / Interest Expense	-	-1.69K	-15.07	-17.14	-153.79
Total Debt / EBITDA	-0.01	-0.57	-0.77	-0.73	-0.46
Net Debt / EBITDA	0.51	0.44	1.24	0.22	0.66
Total Debt / (EBITDA - Capex)	-0.01	-0.57	-0.77	-0.73	-0.46
Net Debt / (EBITDA - Capex)	0.51	0.44	1.24	0.22	0.66
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-11.67	-49.04	-65.07	15.12	-11.55
Gross Profit, 1 Yr. Growth %	65.05	-49.32	-82.24	316.29	-75.56
EBITDA, 1 Yr. Growth %	16.41	76.66	-29.22	8.73	-45.89
EBITA, 1 Yr. Growth %	16.41	76.59	-29.3	8.7	-45.94
EBIT, 1 Yr. Growth %	16.36	76.33	-29.3	8.7	-45.94
Earnings From Cont. Operations, 1 Yr. Growth %	5.12	89.07	-29.04	9.94	-55.5
Net Income, 1 Yr. Growth %	5.12	89.07	-29.04	9.94	-55.5
Normalized Net Income, 1 Yr. Growth %	11.98	85.88	-25.31	8.06	-49.75
Diluted EPS Before Extra, 1 Yr. Growth %	-28.51	33.28	-51.4	2.53	-83.54
Accounts Receivable, 1 Yr. Growth %	-15.22	-80	-31.84	-17.11	48.75
Net Property, Plant and Equip., 1 Yr. Growth %	722.58	55.75	-48.96	180.01	-32.74
Total Assets, 1 Yr. Growth %	-25.89	155.82	35.08	-46.86	-31.39
Tangible Book Value, 1 Yr. Growth %	-77.56	165.86	188.14	-123.06	-202.09
Common Equity, 1 Yr. Growth %	-76.8	156.79	186.56	-123.04	-202.09
Cash From Operations, 1 Yr. Growth %	3.66	52.53	2.49	7.75	-31.98
Capital Expenditures, 1 Yr. Growth %	1.47K	-76.34	64.95	10.89	-
Levered Free Cash Flow, 1 Yr. Growth %	18.77	119.24	-27.48	13.14	-9.93
Unlevered Free Cash Flow, 1 Yr. Growth %	18.77	119.12	-32.33	14.88	-4.76
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-7.68	-32.91	-57.81	-36.58	0.91
Gross Profit, 2 Yr. CAGR %	-2.7